中国循证心血管医学杂志
中國循證心血管醫學雜誌
중국순증심혈관의학잡지
CHINESE JOURNAL OF EVIDENCE-BASES CARDIOVASCULAR MEDICINE
2014年
3期
320-321
,共2页
朱华刚%贾若飞%孟帅%金泽宁
硃華剛%賈若飛%孟帥%金澤寧
주화강%가약비%맹수%금택저
高敏C反应蛋白%高血压
高敏C反應蛋白%高血壓
고민C반응단백%고혈압
High-sensitivity C-reactive protein%Hypertension
目的:探讨血清高敏C反应蛋白水平与中老年人高血压分级的关系。方法选取2013年6月至2013年11月于北京市安贞医院体检的209例中老年人为研究对象,根据中国高血压防治指南2010的诊断标准分为对照组(n=105)和高血压组(n=104),后者再根据高血压程度分为高血压病1、2、3级3个亚组,所有受试者均检测血清高敏C反应蛋白(hs-CRP)水平。结果对照组患者血浆hs-CRP水平为(1.57±2.18)mg/L,高血压组患者hs-CRP水平为(3.91±4.64)mg/L,两组比较差异具有统计学意义(P<0.05)。与高血压病1级hs-CRP水平[(2.95±3.27)mg/L]比较,高血压病2级hs-CRP水平[(5.73±4.00)mg/L]增高,但差异无统计学意义(P>0.05);而高血压病3级hs-CRP水平[(7.60±8.13) mg/L]明显升高,差异有统计学意义(P<0.05)。高血压病3级较高血压病2级hs-CRP水平明显升高(P<0.05)。结论高血压患者血清hs-CRP水平增高,高血压分级越高,血清hs-CRP水平增高越显著。
目的:探討血清高敏C反應蛋白水平與中老年人高血壓分級的關繫。方法選取2013年6月至2013年11月于北京市安貞醫院體檢的209例中老年人為研究對象,根據中國高血壓防治指南2010的診斷標準分為對照組(n=105)和高血壓組(n=104),後者再根據高血壓程度分為高血壓病1、2、3級3箇亞組,所有受試者均檢測血清高敏C反應蛋白(hs-CRP)水平。結果對照組患者血漿hs-CRP水平為(1.57±2.18)mg/L,高血壓組患者hs-CRP水平為(3.91±4.64)mg/L,兩組比較差異具有統計學意義(P<0.05)。與高血壓病1級hs-CRP水平[(2.95±3.27)mg/L]比較,高血壓病2級hs-CRP水平[(5.73±4.00)mg/L]增高,但差異無統計學意義(P>0.05);而高血壓病3級hs-CRP水平[(7.60±8.13) mg/L]明顯升高,差異有統計學意義(P<0.05)。高血壓病3級較高血壓病2級hs-CRP水平明顯升高(P<0.05)。結論高血壓患者血清hs-CRP水平增高,高血壓分級越高,血清hs-CRP水平增高越顯著。
목적:탐토혈청고민C반응단백수평여중노년인고혈압분급적관계。방법선취2013년6월지2013년11월우북경시안정의원체검적209례중노년인위연구대상,근거중국고혈압방치지남2010적진단표준분위대조조(n=105)화고혈압조(n=104),후자재근거고혈압정도분위고혈압병1、2、3급3개아조,소유수시자균검측혈청고민C반응단백(hs-CRP)수평。결과대조조환자혈장hs-CRP수평위(1.57±2.18)mg/L,고혈압조환자hs-CRP수평위(3.91±4.64)mg/L,량조비교차이구유통계학의의(P<0.05)。여고혈압병1급hs-CRP수평[(2.95±3.27)mg/L]비교,고혈압병2급hs-CRP수평[(5.73±4.00)mg/L]증고,단차이무통계학의의(P>0.05);이고혈압병3급hs-CRP수평[(7.60±8.13) mg/L]명현승고,차이유통계학의의(P<0.05)。고혈압병3급교고혈압병2급hs-CRP수평명현승고(P<0.05)。결론고혈압환자혈청hs-CRP수평증고,고혈압분급월고,혈청hs-CRP수평증고월현저。
Objective To investigate the relationship between the level of serum high-sensitivity C-reactive protein (hs-CRP) and blood pressure grading in elderly hypertensive patients. Methods The elderly patients (n=209) were chosen from Beijing Anzhen Hospital from Jun. 2013 to Nov. 2013 as study subjects. According to the diagnostic standard in the Chinese Hypertension Prevention and Cure Guideline (2010), the patients were divided into control group (n=105) and hypertension group (n=104), and hypertension group was divided further into 3 subgroups (grade I subgroup, grade II subgroup and grade III subgroup) according to hypertension grading. The level of serum hs-CRP was detected in all groups. Results The level of serum hs-CRP was (1.57±2.18) mg/L in control group and (3.91±4.64) mg/L in hypertension group (P<0.05). The level of serum hs-CRP increased in grade II subgroup [(5.73±4.00) mg/L] compared with grade I subgroup [(2.95±3.27) mg/L] but the difference had no statistical significance (P>0.05), and increased significantly in grade III subgroup [(7.60±8.13) mg/L] (P<0.05). The level of serum hs-CRP increased significantly in grade III subgroup compared with grade II subgroup (P<0.05). Conclusion The level of serum hs-CRP will increase in hypertensive patients, and the higher the hypertension grading, the more significant the increase of hs-CRP level.